T1	Participants 61 83	breast cancer surgery.
T2	Participants 171 187	female patients.
T3	Participants 271 319	adult patients undergoing breast cancer surgery.
T4	Participants 328 373	Sixty-eight women premedicated with midazolam
T5	Participants 1564 1625	patients after breast cancer surgery with general anesthesia.
